• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用布舍瑞林和人绝经期促性腺激素对多囊卵巢综合征女性进行辅助受孕。

Assisted conception using buserelin and human menopausal gonadotrophins in women with polycystic ovary syndrome.

作者信息

Wada I, Matson P L, Troup S A, Lieberman B A

机构信息

Manchester Fertility Services, BUPA Hospital, Whalley Range, UK.

出版信息

Br J Obstet Gynaecol. 1993 Apr;100(4):365-9. doi: 10.1111/j.1471-0528.1993.tb12981.x.

DOI:10.1111/j.1471-0528.1993.tb12981.x
PMID:8494838
Abstract

OBJECTIVE

To compare the outcome of in vitro fertilisation (IVF) and gamete intrafallopian transfer (GIFT) cycles in women with or without ultrasound features of polycystic ovary syndrome (PCOS).

DESIGN

A consecutive series from January to December 1989.

SUBJECTS

Twenty-five women with PCOS scheduled for assisted conception. The controls were 139 women with normal ovaries.

SETTING

A single centre specialist fertility unit, Manchester, UK.

INTERVENTIONS

Pituitary desensitisation was with buserelin. In the PCOS group ovarian stimulation was with 1 ampoule (75 iu FSH) of hMG/day in 12 women (Group I) and two ampoules/day in 13 (Group II). The controls (Group III) were given two ampoules of hMG daily. Human chorionic gonadotrophin (hCG; 10,000 iu) was given when three follicles measured > or = 20 mm diameter.

MAIN OUTCOME MEASURES

Serum oestradiol (E2) concentrations, number of follicles, clinical pregnancies, features of the ovarian hyperstimulation syndrome (OHS).

RESULTS

Women with PCOS (Groups I or II) had more follicles > or = 14 mm diameter on the day of the hCG injection (P < 0.005), higher serum E2 concentrations on the day after the hCG (P < 0.05) and more oocytes retrieved (P < 0.05) than the controls. The OHS was more prevalent in those with PCOS (32% versus 6.5%; P < 0.05). The clinical pregnancy rate per embryo transfer (27% versus 22%) or gamete transfer (25% versus 39%) and the rate of spontaneous miscarriage (33% versus 12%) were not statistically different.

CONCLUSIONS

The pregnancy rate and outcome of pregnancy following IVF or GIFT in women with or without PCOS are similar. Women with PCOS are at a higher risk of developing OHS.

摘要

目的

比较有无多囊卵巢综合征(PCOS)超声特征的女性体外受精(IVF)和配子输卵管内移植(GIFT)周期的结局。

设计

1989年1月至12月的连续系列研究。

研究对象

25例计划进行辅助受孕的PCOS女性。对照组为139例卵巢正常的女性。

研究地点

英国曼彻斯特的一个单中心专科生育单位。

干预措施

使用布舍瑞林进行垂体脱敏。PCOS组中,12例女性(I组)每天使用1支(75国际单位促卵泡激素)人绝经期促性腺激素(hMG)进行卵巢刺激,13例女性(II组)每天使用2支。对照组(III组)每天给予2支hMG。当三个卵泡直径≥20毫米时,给予人绒毛膜促性腺激素(hCG;10,000国际单位)。

主要观察指标

血清雌二醇(E2)浓度、卵泡数量、临床妊娠情况、卵巢过度刺激综合征(OHS)的特征。

结果

PCOS女性(I组或II组)在注射hCG当天直径≥14毫米的卵泡更多(P<0.005),hCG注射后一天血清E2浓度更高(P<0.05),回收的卵母细胞更多(P<0.05)。OHS在PCOS患者中更常见(32%对6.5%;P<0.05)。每次胚胎移植(27%对22%)或配子移植(25%对39%)的临床妊娠率以及自然流产率(33%对12%)在统计学上无差异。

结论

有无PCOS的女性在IVF或GIFT后的妊娠率及妊娠结局相似。PCOS女性发生OHS的风险更高。

相似文献

1
Assisted conception using buserelin and human menopausal gonadotrophins in women with polycystic ovary syndrome.使用布舍瑞林和人绝经期促性腺激素对多囊卵巢综合征女性进行辅助受孕。
Br J Obstet Gynaecol. 1993 Apr;100(4):365-9. doi: 10.1111/j.1471-0528.1993.tb12981.x.
2
Does elective cryopreservation of all embryos from women at risk of ovarian hyperstimulation syndrome reduce the incidence of the condition?对有卵巢过度刺激综合征风险的女性的所有胚胎进行选择性冷冻保存是否会降低该病症的发生率?
Br J Obstet Gynaecol. 1993 Mar;100(3):265-9. doi: 10.1111/j.1471-0528.1993.tb15241.x.
3
High ovarian response in Yoruba African women during ovulation induction for assisted conception.约鲁巴族非洲女性在辅助受孕促排卵过程中的高卵巢反应。
Hum Reprod. 1994 Jun;9(6):1077-80. doi: 10.1093/oxfordjournals.humrep.a138636.
4
Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome.在体外成熟过程中暴露于人类绒毛膜促性腺激素并不能提高多囊卵巢综合征患者未成熟卵母细胞的成熟率和发育潜能。
Fertil Steril. 2008 Jan;89(1):98-103. doi: 10.1016/j.fertnstert.2007.02.021. Epub 2007 May 24.
5
Serum and follicular fluid (FF) estradiol (E2) levels in ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) and gamete intrafallopian transfer (GIFT) conception cycles after pituitary suppression.垂体抑制后体外受精(IVF)和配子输卵管内移植(GIFT)受孕周期中卵巢过度刺激综合征(OHSS)患者的血清和卵泡液(FF)雌二醇(E2)水平。
J In Vitro Fert Embryo Transf. 1991 Jun;8(3):137-40. doi: 10.1007/BF01131702.
6
[Clinical analysis of assistant treatment proposals for infertile women with polycystic ovary syndrome].[多囊卵巢综合征不孕女性辅助治疗方案的临床分析]
Zhonghua Fu Chan Ke Za Zhi. 2008 Aug;43(8):571-5.
7
Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome.孤立性多囊卵巢或多囊卵巢综合征女性的卵母细胞质量与卵胞浆内单精子注射结局的比较。
Arch Gynecol Obstet. 2008 Mar;277(3):239-44. doi: 10.1007/s00404-007-0462-x. Epub 2007 Sep 25.
8
Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.口服避孕药与促性腺激素释放激素激动剂联合抑制可改善高反应患者的体外受精结局。
Hum Reprod. 1997 Nov;12(11):2359-65. doi: 10.1093/humrep/12.11.2359.
9
[Effects of dyslipidemia on IVF/ICSI pregnancy outcome in patients with polycystic ovary syndrome].[血脂异常对多囊卵巢综合征患者体外受精/卵胞浆内单精子注射妊娠结局的影响]
Zhonghua Fu Chan Ke Za Zhi. 2018 Jun 25;53(6):402-408. doi: 10.3760/cma.j.issn.0529-567x.2018.06.008.
10
The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.低剂量人绒毛膜促性腺激素联合人绝经期促性腺激素方案对接受体外受精卵巢刺激的低促性腺激素性性腺功能减退症妇女的影响。
Clin Endocrinol (Oxf). 2018 Jan;88(1):77-87. doi: 10.1111/cen.13481. Epub 2017 Oct 16.

引用本文的文献

1
Polycystic ovary syndrome: pathophysiology and therapeutic opportunities.多囊卵巢综合征:病理生理学与治疗机遇
BMJ Med. 2023 Oct 12;2(1):e000548. doi: 10.1136/bmjmed-2023-000548. eCollection 2023.
2
Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment.在体外受精治疗中诱导卵母细胞最终成熟的新概念。
Endocr Rev. 2018 Oct 1;39(5):593-628. doi: 10.1210/er.2017-00236.
3
Clinical parameters of ovarian hyperstimulation syndrome following different hormonal triggers of oocyte maturation in IVF treatment.
不同激素触发卵母细胞成熟在 IVF 治疗中对卵巢过度刺激综合征的临床参数。
Clin Endocrinol (Oxf). 2018 Jun;88(6):920-927. doi: 10.1111/cen.13569. Epub 2018 Mar 6.
4
A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial.促黄体激素释放激素 54 对高风险卵巢过度刺激综合征患者卵母细胞成熟的改善作用:一项 2 期随机对照试验。
Hum Reprod. 2017 Sep 1;32(9):1915-1924. doi: 10.1093/humrep/dex253.
5
Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy.kisspeptin-54在体外受精(IVF)治疗期间对卵巢过度刺激综合征(OHSS)高危女性触发卵母细胞成熟的疗效。
J Clin Endocrinol Metab. 2015 Sep;100(9):3322-31. doi: 10.1210/jc.2015-2332. Epub 2015 Jul 20.